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Introduction: Osteoarthritis (OA) is the most common musculoskeletal disorder and 
represents a major health burden to society.  In the course of the pathological development of 
OA, articular cartilage chondrocytes (ACCs) undergo a typical phenotype changes 
characterized by the expression of hypertrophic differentiation markers. Also, the adjacent 
subchondral bone shows signs of abnormal mineral density and enhanced production of bone 
turnover markers, indicative of osteoblast dysfunction.  However, the mechanism(s) by which 
these changes occur during the OA development are not completely understood.  
Materials and Methods: ACCs and subchondral bone osteoblasts (SBOs) were harvested 
from OA and healthy patients for the cross-talk studies between normal and OA ACCs and 
SBOs. The involvement of mitogen activated protein kinase (MAPK) signalling pathway 
during the cell-cell interactions was analysed by zymography, ELISA and western blotting 
methods.  
Results: The direct and in-direct co-culture studies showed that OA (ACCs and SBOs) cells 
induced osteoarthritic changes of normal (ACC and SBOs) cells. This altered cell interaction 
induced by OA cells significantly aggravated the proteolytic activity, which resulted cartilage 
degeneration. The altered cell interaction appeared to significantly activate ERK 1/2 
phosphorylation and inhibition of MAPK-ERK 1/2 pathway reversed the osteoarthrtitic 
phenotypic changes.   
Discussion and Conclusion: Our study has demonstrated that the altered bi-directional 
communication of SBOs and ACCs are critical for initiation and progression of OA related 
changes and that this process is mediated by MAPK signalling pathways. Targeting these 
altered interactions by the use of MAPK inhibitors may provide the scientific rationale for the 
development of novel therapeutic strategies in the treatment and management of OA related 
disorders.  
